Cited by 30Pituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersAdrenal and Paraganglionic Tumors

Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing’s syndrome?

Krarup, Therese, Krarup, Thure, Hagen, Claus·2012·Diabetes/Metabolism Research and Reviews

Abstract

Many clinical features are common for patients with type 2 diabetes mellitus (T2DM) and Cushing's syndrome (CS) such as central obesity, hypertension and dyslipidaemia. Patients with CS often have T2DM. Because T2DM is much more frequent than CS, it is possible that some patients with T2DM have increased production of cortisol and thus represent patients with CS. The aim of this review was to evaluate the prevalence of CS in patients with T2DM. A search was performed in PubMed and Medline. We found seven prospective studies, two case-control studies and two cross-sectional studies. The difficulties in diagnosing subclinical CS is discussed. The most frequent tests for diagnosing CS, late-night salivary cortisol, 1-mg dexamethasone suppression test and urinary free cortisol are discussed and put in relation to the results of the literature found. The observed prevalence of CS in patients with T2DM varies widely between the different studies, ranging from 0-9.4%. This may be due to patient selection, differences in test methodology (including choice of test), cutoff values and different cortisol assays. The true prevalence of CS in T2DM has not been determined. We need more studies investigating the prevalence of CS in T2DM patients. There is a need for developing more specific tests for diagnosing CS in patients with only slightly elevated cortisol secretion and subclinical CS. We suggest that examination for hypercortisolism should only be performed in T2DM patients with a cushingoid appearance and hypertension or truncal obesity or dyslipidaemia.

Integrity signals

Registry

Crossref · 10.1002/dmrr.2262

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The frequency of Cushing syndrome in an unselected type 2 diabetes population was too low compared with false-positive results to make routine screening applicable, given high cost-effectiveness and lack of specific tests.

    “On the other hand, the frequency of CS identified in an unselected population of type  DM patients was too low compared with the number of false-positive results to make a routine screening strategy applicable in practice (), given its high cost-effectiveness and the lack of specific tests for diagnosing CS, especially in patients with a slightly elevated cortisol secretion and SCS ().”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Krarup, T., Krarup, T., & Hagen, C.
Affiliations
Bispebjerg Hospital (DK)
Corresponding author
Krarup, Therese
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2012-03
Volume
28
Issue
3
Pages
219-227
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W1915288881
Cited by
30
References
58
Citations by year
2025: 3 · 2022: 5 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 2
FWCI
0.22
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes/Metabolism Research and Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords
Cushing's syndrome, type 2 diabetes, prevalence, hypercortisolism, subclinical Cushing's syndrome, cortisol measurement, late-night salivary cortisol, dexamethasone suppression test, urinary free cortisol, abdominal obesity, hypertension, dyslipidemia
MeSH terms
Cross-Sectional Studies, Cushing Syndrome, Dexamethasone, Diabetes Mellitus, Type 2, Humans, Hydrocortisone, Hypertension, Prospective Studies, United States, Prevalence, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review